Helicobacter pylori antigen hla-restricted immunodominant epitope peptide and its application

A Helicobacter pylori and dominant epitope technology, applied in the field of medical biology, can solve problems such as low accuracy, missed screening, and treatment failure, and achieve the goal of avoiding missed and wrong screening, reducing the risk of use, and expanding the width Effect

Active Publication Date: 2011-12-14
ARMY MEDICAL UNIV
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although it can achieve an eradication rate of 85%, it has the following disadvantages: 1. Drug therapy has large toxic and side effects; 2. Complicated drug combination leads to poor patient compliance; 3. Drugs cannot prevent the potential infection of H. pylori; 4. Antibiotic treatment is easy to produce Drug dependence leads to treatment failure; 5. For patients in developing countries, drug therapy is also economically difficult
[0006] At present, the reported Hp antigen CD4+ T cell epitopes are all mouse H-2 restricted Th epitopes. Due to the difference between mouse and human MHC molecules, H-2 restricted epitopes may not be suitable for human vaccine design , so it is necessary to screen for the identification of HLA-restricted epitopes
In addition, currently reported Hp epitopes are mostly predicted by bioinformatics software, and the accuracy rate is not high. Although it can be verified through experiments, the phenomenon of epitope leakage cannot be avoided.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Helicobacter pylori antigen hla-restricted immunodominant epitope peptide and its application
  • Helicobacter pylori antigen hla-restricted immunodominant epitope peptide and its application
  • Helicobacter pylori antigen hla-restricted immunodominant epitope peptide and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] HpaA is a subunit of Helicobacter pylori flagellin protein A, and its sequence is conserved among various strains, with a total length of 260 amino acids, of which 1-27 amino acids are signal peptides. The recombinantly constructed rHpaA is a 28-260 polypeptide derived from the 11637 international standard strain. Therefore, the HpaA protein sequence (No. P55969) derived from Helicobacter pylori 11637 was retrieved in the UniProt protein database, and a short peptide with 18 amino acid steps overlapping was synthesized from the 28th amino acid (synthesized with the assistance of Shanghai Gil Biochemical Company), a total of 37 ( The last one is a 17 amino acid short peptide). The purity is greater than 90%. The synthetic peptide information is shown in Table 1. The synthesized peptides were dissolved in DMSO to a storage concentration of 5 mM, and 10 μL of each of 37 short peptides were mixed together to form a peptide library. Store at -70°C after aliquoting.

[00...

Embodiment 2

[0054] 2.1 Collection and storage of PBMC from positive Hp infection patients

[0055] The peripheral blood of Hp positive patients was obtained from the Chongqing Blood Station of the People’s Liberation Army. 13 For those positive for Helicobacter pylori infection screened by urease breath test, buffy coat cells were collected after blood collection, and then PBMCs were separated with Ficoll-diatrizoate lymphocyte separation medium (Tianjin TBD Company) according to the actual instructions. The isolated PBMCs were resuspended to a cell density of 1×10 7 / mL, add 1mL / tube into a cryopreservation tube, put it in a freezer box at -70°C for overnight, and then transfer it to liquid nitrogen for cryopreservation.

[0056] 2.2 ICS method to detect the frequency of HpaA-specific CD4+ T cells in PBMC of Hp positive patients

[0057] Resuscitate a tube of PBMCs positive for Hp infection, resuspend the cells with RPMI-1640 complete medium to 5×106 / ml, and spread 0.2ml of cell suspen...

Embodiment 3

[0062] 3.1 Methods for expanding antigen-specific T cells in vitro

[0063] Adjust the concentration of PBMC cells in patients with positive Hp infection to 2.5×10 6 / ml, inoculate in 48-well cell culture plate (1ml / well), add appropriate amount of HpaA antigen, mix well and incubate at 37°C, 5% CO 2 cultivated under conditions. On the fifth day, a low dose of recombinant human IL-2 (rhIL-2) (final concentration 25 U / ml) was added. On the 8th day, the culture medium began to turn yellow, and half of the medium was changed (the culture medium replaced contained 25 U / ml rhIL-2, and the cells were subcultured in different wells in due course.

[0064] 3.2 Detection of antigen-specific T cells in vitro

[0065] After the effective expansion of antigen-specific CD4+ T cells in vitro, the frequency has reached the detection range of ICS, and the frequency of antigen-specific CD4+ T cells was detected by ICS method. Collect the cultured cells, centrifuge to remove the medium cont...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a helicobacter pylori antigen HLA restricted immuno-dominant epitope peptide and an application thereof. The helicobacter pylori HpaA antigen immuno-dominant epitope polypeptide has amino acid sequences as shown in SEQ ID No:8, 22, 30 and 42. The polypeptide of the invention has high immunogenicity, and can initiate strong immune response. Additionally, the immuno-dominant epitope polypeptide does not contain unnecessary or even harmful parts, and thus application risk of vaccines prepared by the polypeptide is reduced. Superiority combination of the immuno-dominant epitope polypeptide with other vaccine components can be realized, which extends the width of immune response. Vaccines prepared by the immuno-dominant epitope polypeptide not only have prevention effect on helicobacter pylori infection, but also can be used as therapeutic vaccines.

Description

technical field [0001] The invention belongs to the technical field of medicine and biology, and relates to a method for screening and identifying antigenic epitope peptides, in particular to a Helicobacter pylori antigen HLA-restricted immunodominant epitope peptide and its application. Background technique [0002] Helicobacter pylori (Hp) was discovered in 1982 by Australian scholars Warren and Marshall. In the past nearly 30 years, studies have confirmed that Hp is the main cause of gastritis, gastric ulcer, and duodenal ulcer, and is closely related to the occurrence of gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma (MALT). Listed as a class I carcinogen for gastric cancer. Moreover, the infection rate of Hp is very high. Epidemiological surveys show that 50% of the population in the world carries this bacterium, especially in some developing countries, the infection rate is even as high as 80%. Therefore, effective treatment of Hp infection is ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/08A61K39/02A61P31/04
Inventor 吴超邹全明陈立罗萍石云赵卓余抒
Owner ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap